Smoking significantly increases the risk of developing type 2 diabetes and severely complicates glycemic control for those already living with the disease, accelerating life-threatening cardiovascular and microvascular complications.
- Elevated Risk: Active smoking increases the likelihood of developing type 2 diabetes by 30 to 40 times compared to non-smokers.
- Metabolic Disruption: Nicotine and tobacco toxins directly damage pancreatic beta cells, induce oxidative stress, and trigger severe insulin resistance.
- Amplified Complications: Diabetic smokers face drastically higher rates of heart attacks, strokes, kidney disease, and nerve damage.
- Cessation Benefits: Quitting smoking restores insulin sensitivity over time, and the long-term cardiovascular benefits far outweigh temporary withdrawal symptoms like weight gain.
Public Health France data reveals a concerning reality: nearly 410,000 people living with diabetes continue to smoke, despite tobacco being the leading cause of death from all causes in this demographic. This ongoing exposure to toxic chemicals directly disrupts carbohydrate metabolism, worsening diabetic complications and severely impairing glycemic control.
Currently, more than 4 million people in France live with diabetes, representing nearly 6.5% of the population. While the prevalence of daily smoking in the general adult population sits at 18.2%, approximately a quarter of individuals with type 1 diabetes (T1D) and nearly 13% of those with type 2 diabetes (T2D) remain active smokers.
Smoking is not just a hazard for those already diagnosed; it is a major recognized risk factor for the development of type 2 diabetes, prediabetes, and gestational diabetes. By promoting severe metabolic imbalances, tobacco smoke creates a dangerous environment within the body that facilitates the onset of chronic hyperglycemia.
The Direct Metabolic Effects of Smoking
When it comes to tobacco and diabetes, there is a clear dose-response effect: the more cigarettes a person smokes, the higher the risk of developing the disease and the more severe the subsequent complications become. Tobacco smoke contains over 7,000 chemical substances, including heavy metals, toxic compounds, and nicotine.
These substances do not remain confined to the lungs. They circulate throughout the entire bloodstream, disrupting vital bodily functions and directly interfering with carbohydrate metabolism through several key mechanisms:
- Pancreatic Beta Cell Damage: Nicotine physically reduces the mass and function of pancreatic beta cells, which are responsible for insulin production. This directly disrupts glucose regulation.
- Low-Grade Inflammation: Smoking triggers chronic inflammation that interferes with insulin signaling within cells, severely reducing their ability to absorb glucose from the bloodstream.
- Oxidative Stress: Aggressive molecules from tobacco smoke damage cells, tissues, and insulin receptors. Studies indicate that acute impairment of glucose tolerance can occur after smoking just three cigarettes, even in non-smokers.
- Endothelial Dysfunction: Carbon monoxide impairs the inner lining of blood vessels (the endothelium), making them less efficient at transporting oxygen and nutrients, which exacerbates metabolic disorders.
Furthermore, smoking promotes the accumulation of abdominal fat, increases the secretion of free fatty acids, and disrupts hormonal balance. All of these factors culminate in severe insulin resistance, creating a scenario where active smoking—and to a lesser extent, passive smoking—amplifies the risk of developing type 2 diabetes by 30 to 40 times.
How Tobacco Disrupts Existing Diabetes Management
For individuals already living with diabetes, the effects of tobacco are highly detrimental. Smoking directly influences blood glucose regulation and insulin function, making daily management incredibly complex.
Nicotine stimulates the production of hyperglycemic hormones known as catecholamines, which include adrenaline. The release of these hormones causes a spike in blood glucose levels, heart rate, and blood pressure. Simultaneously, these hormones disrupt both the secretion of insulin and the transport of glucose into the body’s cells.
Because of these constant, chemically induced fluctuations, achieving stable blood sugar becomes a moving target. This persistent imbalance drastically increases the risk of major, life-altering complications associated with diabetic disease.
Severe Complications Amplified by Smoking
In diabetic patients who smoke, the progression of both microvascular (small blood vessel) and macrovascular (large blood vessel) complications is significantly accelerated.
The risk of cardiovascular disease is already inherently high in people with diabetes, but tobacco use acts as a massive multiplier for life-threatening events.
| Macrovascular Complication | Increased Risk Due to Smoking (in Diabetic Patients) |
|---|---|
| Myocardial Infarction (Heart Attack) | + 51% |
| Stroke | + 54% |
| Peripheral Arterial Disease | + 115% |
Beyond major cardiac events, smoking heavily exacerbates microvascular and other systemic complications:
- Diabetic Nephropathy: Smoking is an independent driver of kidney damage, accelerating the progression toward end-stage renal disease.
- Diabetic Neuropathy: Tobacco damages nerves and restricts blood circulation, leading to severe pain, sensory loss, an increased risk of foot ulcers, infections, and ultimately, amputations.
- Diabetic Retinopathy: Toxic smoke damages the delicate blood vessels of the retina, actively contributing to vision loss and blindness.
- Cancer Risk: Type 2 diabetes already increases the risk of all-cause cancer by at least 60% (particularly pancreatic, liver, and colorectal). Smoking compounds this risk exponentially.
- Poor Healing and Oral Health: The combination of diabetes and tobacco slows wound healing, increases infection rates, and promotes severe periodontal disease.
The Journey of Smoking Cessation for Diabetics
Quitting smoking offers profound, life-saving benefits for people with diabetes, significantly reducing the risk of cardiovascular disease, microvascular complications, and all-cause mortality. However, the cessation process requires careful management.
Weight gain is a common concern during withdrawal. This occurs due to a decrease in basal metabolism and an increase in appetite once nicotine’s appetite-suppressing effects fade. While some patients (about 13%) may gain up to 10 kg, others (16%) do not gain weight, or even lose weight with proper support.
Blood sugar imbalances may temporarily occur in the months following cessation. However, this is offset by a gradual, long-term improvement in insulin sensitivity. After approximately three years of abstinence, blood sugar levels normalize and closely resemble those of non-smokers. Furthermore, the cardiovascular benefits begin to manifest rapidly after quitting, regardless of weight fluctuations.
To optimize cessation, nutritional guidance and properly dosed nicotine replacement therapies are essential. The French-Speaking Society of Tobacco Studies (SFT) and the French-Speaking Society of Diabetes (SFD) emphasize the need to adjust carbohydrate intake to maintain satiety and prevent compensatory snacking. For type 1 diabetics, rapid-acting insulin doses can be adjusted based on carbohydrate intake, making functional insulin therapy training highly beneficial.
Are E-Cigarettes and Heated Tobacco Safe Alternatives?
As traditional smokers look for alternatives, new tobacco products are often perceived as less harmful. However, they are not without risks for people living with diabetes.
While available data is currently limited, initial studies indicate that the use of electronic cigarettes (vaping) may be associated with increased glucose intolerance and a higher risk of developing type 2 diabetes. Similarly, heated tobacco products appear to elevate this metabolic risk, though further scientific confirmation is required.
Ultimately, smoking and diabetes are a dangerous combination. Smoking cessation remains the single most effective intervention for reducing severe health risks, stabilizing blood sugar, and improving the overall quality of life for diabetic patients.
[1] Data.ameli.fr (2023). Available on https://data.ameli.fr/pages/pathologies/?refine.patho_niv1=Diab%C3%A8te
[2] DURLACH, Vincent, VERGÈS, B., AL-SALAMEH, A., et al. Smoking and diabetes interplay: a comprehensive review and joint statement. Diabetes & Metabolism, 2022, vol. 48, no. 6, art. 101370. Available at: https://pubmed.ncbi.nlm.nih.gov/35779852/
[3] TISSOT, Catherine, and NIKPEYMA, Atefeh. Smoking and diabetes: a risk to consider and a major dietary challenge. Dietary Information, 2025, no. 2, pp. 15-21.
[4] FOSSE-EDORH, Sandrine, PIFFARETTI, Cécile, SABONI, Lucile, et al. Entred studies: a system to improve knowledge of the health status of people with diabetes in France – First results of the third edition conducted in metropolitan France in 2019. Weekly Epidemiological Bulletin, 2022, no. 22, pp. 384-391. Available at https://beh.santepubliquefrance.fr/beh/2022/22/2022_22_1.html
[5] Sharp decline in smoking in FranceIn 10 years, 4 million fewer daily smokers. https://www.santepubliquefrance.fr/presse/2025/forte-baisse-du-tabagisme-en-france-en-10-ans-4-millions-de-fumeurs-quotidiens-en-moins . Accessed March 17, 2026.
[6] DURLACH, Vincent, VERGÈS, Bruno, AL-SALAMEH, Abdallah, et al. Smoking and diabetes: time for action. Weekly Epidemiological Bulletin, November 8, 2022, No. 22, pp. 392–398. Available at: https://beh.santepubliquefrance.fr/beh/2022/22/pdf/2022_22_2.pdf
[7] World Health Organization, 2025. Summary of knowledge about tobacco. Geneva: World Health Organization. Available at: https://www.who.int/fr/publications/b/80110
[8] SUN, Lingli, WANG, Xiaohua, GU, Tianye, HU, Baoying, LUO, Jiashan, QIN, Yi, and al. Nicotine triggers islet β cell senescence to facilitate the progression of type 2 diabetes. Toxicology, 2020, vol. 441, art. 152502. Available at: https://pubmed.ncbi.nlm.nih.gov/32473187/
[9] TONG, Xin, CHAUDHRY, Zunaira Z., LEE, Chih-Chun CC, BONE, Robert NRN, KANOJIA, Sukrati, MADDATU, Judith J., et al. Cigarette smoke exposure impairs β-cell function through activation of oxidative stress and ceramide accumulation. Molecular Metabolism, 2020, vol. 37, art. 100975. Available at: https://pubmed.ncbi.nlm.nih.gov/32283079/
[10] Li, Z., Xu, W., Su, Y., Gao, K., Chen, Y., Ma, L. & Xie, Y., 2019. Nicotine induces insulin resistance via downregulation of Nrf2 in cardiomyocyte. Molecular and Cellular Endocrinology, 495, p.110507. Available at: https://pubmed.ncbi.nlm.nih.gov/31315024/
[11] Artese, A., Stamford, BA & Moffatt, RJ, 2017. Cigarette smoking: an accessory to the development of insulin resistance. American Journal of Lifestyle Medicine, 13(6), pp.602–605. Available at: https://pubmed.ncbi.nlm.nih.gov/31662726/
[12] THUILLIER, P., and MANSOURATI, J. What are the links between smoking and insulin resistance, insulin sensitivity? Metabolic Disease Medicine, 2023, vol. (number not specified), art. S1957255723000202. Available at: https://www.sciencedirect.com/science/article/abs/pii/S1957255723000202
[13] DURLACH, Vincent, VERGÈS, Bruno, AL-SALAMEH, Abdallah, et al. Smoking and diabetes: time for action. Weekly Epidemiological Bulletin, November 8, 2022, No. 22, pp. 392–398. Available at: https://beh.santepubliquefrance.fr/beh/2022/22/pdf/2022_22_2.pdf
[14] US Department of Health and Human Services. The Health Consequences of Smoking — 50 Years of Progress: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US), National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014. Available at: https://www.ncbi.nlm.nih.gov/books/NBK179276/
[15] World Health Organization, 2025. Summary of knowledge about tobacco. Geneva: World Health Organization. Available at: https://www.who.int/fr/publications/b/80110
[16] Hu, Y., Zong, G., Liu, G., et al., 2018. Smoking cessation, weight change, type 2 diabetes, and mortality. The New England Journal of Medicine, 379(7), pp.623–632. Available at: https://www.nejm.org/doi/full/10.1056/NEJMoa1803626
[17] Ravelli, AC, van der Meulen, JH, Osmond, C., Barker, DJ & Bleker, OP, 1999. Obesity at the age of 50 in men and women exposed to famine prenatally. American Journal of Clinical Nutrition, 70(5), pp.811–816. Available at: https://pubmed.ncbi.nlm.nih.gov/10539740/
[18] DURLACH, Vincent, VERGÈS, Bruno, AL-SALAMEH, Abdallah, et al. Smoking and diabetes: time for action. Weekly Epidemiological Bulletin, November 8, 2022, No. 22, pp. 392–398. Available at: https://beh.santepubliquefrance.fr/beh/2022/22/pdf/2022_22_2.pdf
[19] DURLACH, Vincent, VERGÈS, Bruno, AL-SALAMEH, Abdallah, et al. Smoking and diabetes: time for action. Weekly Epidemiological Bulletin, November 8, 2022, No. 22, pp. 392–398. Available at: https://beh.santepubliquefrance.fr/beh/2022/22/pdf/2022_22_2.pdf
[20] THUILLIER, P., and MANSOURATI, J. What are the links between smoking and insulin resistance, insulin sensitivity? Metabolic Disease Medicine, 2023, vol. (number not specified), art. S1957255723000202. Available at: https://www.sciencedirect.com/science/article/abs/pii/S1957255723000202
[21] US Department of Health and Human Services. The Health Consequences of Smoking — 50 Years of Progress: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US), National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014. Available at: https://www.ncbi.nlm.nih.gov/books/NBK179276/
[22] Clair, C., Cohen, M. J., Eichler, F., Selby, K. J. & Rigotti, N. A., 2015. The effect of cigarette smoking on diabetic peripheral neuropathy: a systematic review and meta-analysis. Journal of General Internal Medicine, 30(8), pp.1193–1203. Available at: https://pubmed.ncbi.nlm.nih.gov/25947882/
[23] Chakkarwar, VA, 2012. Smoking in diabetic nephropathy: sparks in the fuel tank? World Journal of Diabetes, 3(12), pp.186–195. Available at: https://pubmed.ncbi.nlm.nih.gov/23301120/
[24] Xia, N., Morteza, A., Yang, F., Cao, H. & Wang, A., 2019. Review of the role of cigarette smoking in diabetic foot. Journal of Diabetes Investigation, 10(2), pp.202–215. Available at: https://pubmed.ncbi.nlm.nih.gov/30300476/
[25] St Claire S, Aarsand R, Cui M, Tursan d’Espaignet E, Mueller A, Fayokun R et al. WHO tobacco knowledge summaries: tobacco and vision loss. Geneva: World Health Organization; 2022. Available on: https://www.drugsandalcohol.ie/37965/1/WHO_Tobacco_and_vision_loss.pdf
[26] World Health Organization, 2025. Summary of knowledge about tobacco. Geneva: World Health Organization. Available at: https://www.who.int/fr/publications/b/80110
[27] Sun, Q., Liu, G., Willett, WC, et al., 2020. Smoking cessation and weight change in relation to cardiovascular disease and mortality among adults with type 2 diabetes mellitus. Lancet Diabetes & Endocrinology, 8(8), pp.649–659. Available at: https://pubmed.ncbi.nlm.nih.gov/31924561/
[28] After 1 year of abstinence and usually within the first 6 months
[29] Aubin, HJ, Farley, A., Lycett, D., Lahmek, P. & Aveyard, P., 2012. Weight gain in smokers after quitting cigarettes: meta‑analysis. BMJ, 345, p.e4439. Available at: https://www.bmj.com/content/345/bmj.e4439
[30] Tramunt, B. & Durlach, V., 2023. Smoking cessation and diabetes: what benefits for what risks? Metabolic Disease Medicine, 17(2), pp.125–131. Available at: https://www.researchgate.net/publication/368480646_Sevrage_tabagique_et_diabete_quels_benefices_pour_quels_risques
[31] Clair, C., Rigotti, N. A., Porneala, B., Fox, C. S., D’Agostino, R. B., Pencina, M. J. & Meigs, J. B., 2013. Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. JAMA, 309(10), pp.1014–1021. Available at: https://pubmed.ncbi.nlm.nih.gov/23483176/
[32] TISSOT, Catherine, and NIKPEYMA, Atefeh. Smoking and diabetes: a risk to consider and a major dietary challenge. Dietary Information, 2025, no. 2, pp. 15-21.
[33] IBIDEM
[34] Sivandzade, F. & Cucullo, L., 2019. Assessing the protective effect of rosiglitazone against electronic cigarette/tobacco smoke‑induced blood–brain barrier impairment. BMC Neuroscience, 20, article 15. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC6449906/
[35] Kim, D., Choy, YS & Park, E.‑C., 2017. Association between secondhand smoke and glycemic control in adult diabetes patients. Preventive Medicine, 94, pp. 48–54. Available at: https://pubmed.ncbi.nlm.nih.gov/27856339/